Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin for divergent thinking and goal-directed behavior in healthy volunteers
NL-OMON49008Active, not recruiting
- Sponsor
- Maastricht University
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of psilocybin and ketanserin (2 arms), sponsored by Maastricht University. Primary endpoints: Divergent thinking and Goal-directed versus habitual behavior. Started Jul 2017; status: active, not recruiting.
02
Drugs
psilocybinketanserin
Beyond the preview
Go deeper on NL-OMON49008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49008.